doxorubicin hydrochloride has been researched along with Leukemia, Myeloid, Acute in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, Y; Ding, YH; Gao, X; Kuang, BJ; Long, J; Zhang, Q | 1 |
| Chen, Y; Ding, Y; Gao, Y; Ge, W; Kang, N; Kuang, B; Lian, L; Wei, Y; Yang, Z; Zhang, Q | 1 |
2 other study(ies) available for doxorubicin hydrochloride and Leukemia, Myeloid, Acute
| Article | Year |
|---|---|
Dispirocyclopropyldehydrocostus lactone selectively inhibits acute myelogenous leukemia cells.
Topics: Animals; Apoptosis; bcl-2-Associated X Protein; Caspase 3; Caspase 9; Cell Line, Tumor; Cell Survival; Drug Screening Assays, Antitumor; Humans; Lactones; Leukemia, Myeloid, Acute; Mice; Mice, SCID; Neoplasms; Poly(ADP-ribose) Polymerases; Prodrugs; Sesquiterpenes; Transplantation, Heterologous; Up-Regulation | 2016 |
Synthesis and anti-acute myeloid leukemia activity of C-14 modified parthenolide derivatives.
Topics: Antineoplastic Agents; Apoptosis; Cell Proliferation; Chemistry Techniques, Synthetic; Drug Design; HL-60 Cells; Humans; Leukemia, Myeloid, Acute; Sesquiterpenes; Structure-Activity Relationship | 2017 |